Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Long-Term Investments (2016)

Historic Long-Term Investments for Niagen Bioscience (NAGE) over the last 5 years, with Q4 2016 value amounting to $20318.0.

  • Niagen Bioscience's Long-Term Investments changed N/A to $20318.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $20318.0, marking a year-over-year change of. This contributed to the annual value of $20318.0 for FY2016, which is N/A changed from last year.
  • Niagen Bioscience's Long-Term Investments amounted to $20318.0 in Q4 2016.
  • Niagen Bioscience's Long-Term Investments' 5-year high stood at $2.7 million during Q1 2013, with a 5-year trough of $20318.0 in Q4 2016.